/
MYCOF
$2.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $2.04
98% from low
Exchange
OTC Link
OS
Borrow rate
28.74%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-273.50
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $207.7K | $125.6K | $2.6K | $7.5K | $0 | $0 | $0 | $0 |
| Cost of revenue | $109.8K | $94.0K | $0 | $0 | $128.9K | $9.9K | $0 | $0 |
| Gross profit | $97.8K | $31.5K | $2.6K | $7.5K | −$128.9K | −$9.9K | $0 | $0 |
| Gross margin | 47.1% | 25.1% | 100.0% | 100.0% | — | — | — | — |
| R&D | $0 | $0 | $1.3M | $4.0M | $3.6M | $1.1M | $0 | −$40.1K |
| Operating income | −$5.8M | −$3.3M | −$11.2M | −$22.1M | −$15.7M | −$9.4M | −$2.5M | −$549.9K |
| EBITDA | −$5.8M | −$21.3M | −$11.2M | −$23.1M | −$15.7M | −$9.4M | −$2.5M | $3.1M |
| Net income | −$13.4M | −$3.7M | −$26.9M | −$28.9M | −$11.8M | −$20.9M | −$3.2M | $2.9M |
| Net margin | -6431.4% | -2968.2% | -1029764.8% | -385658.6% | — | — | — | — |
| EPS (diluted) | -122.07 | -8.37 | -11.82 | -6.17 | -1.37 | -0.68 | -0.05 | 2.37 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $112435 | $-224.87 | $-224.87–$-224.87 | 1 |
| 2027 | $12M | $-209.82 | $-209.82–$-209.82 | 1 |
| 2028 | $107M | $160.95 | $160.95–$160.95 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
NOVERIS HEALTH SCIENCES
NOVERIS HEALTH SCIENCES
Held by traders on TradeandTell
No one on the platform currently holds MYCOF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in MYCOF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-10-21 | 1-for-50reverse |
| 2022-04-21 | 1-for-50reverse |
Recent trades on TradeandTell
No one on the platform has traded MYCOF yet.